Bearish flow noted in aTyr Pharma (ATYR) Inc with 10,964 puts trading, or 9x expected. Most active are Aug-25 5 puts and Aug-25 6 calls, with total volume in those strikes near 5,700 contracts. The Put/Call Ratio is 2.58, while ATM IV is up over 49 points on the day. Earnings are expected on August 14th.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATYR:
- aTyr Pharma management to meet with Cantor Fitzgerald
- High-Risk, High-Reward Opportunity in aTyr Pharma’s Efzofitimod Amid Upcoming Phase 3 Readout
- Optimistic Buy Rating for aTyr Pharma Driven by Promising Phase 3 Progress of Efzofitimod in Pulmonary Sarcoidosis
- aTyr Pharma announces last patient visit in Phase 3 EFZO-FIT study
- Promising Outlook for aTyr Pharma’s Efzofitimod Drives Buy Rating Amid Strong Market Potential